drugset / Trial / NCT02053935

Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects

NCT02053935

Phase 1 Completed 15 enrolled Albert Einstein College of Medicine
NaSingle-groupOpen-labelTreatment

Summary

This is a clinical study of a drug named dopamine and how it affects our bodies ability to make and secrete insulin. Insulin is a hormone made in the pancreas that helps our body regulate sugar levels. We think that this drug decreases the amount of insulin our body makes and causes our sugar levels to be high. When you are critically ill there can be many adverse effects if you have sugar levels that are too high.

Timeline

Start
2013-12
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dopamine Small molecule 5 ug/kg Intravenous